Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VV, Pasinetti G, Zhang W, Inglese M, Calabresi PA, Wu G, Miller AE, Haughey NJ, Lublin FD, Casaccia P. Vidaurre OG, et al. Among authors: calabresi pa. Brain. 2014 Aug;137(Pt 8):2271-86. doi: 10.1093/brain/awu139. Epub 2014 Jun 3. Brain. 2014. PMID: 24893707 Free PMC article.
Granzyme B mediates neurotoxicity through a G-protein-coupled receptor.
Wang T, Allie R, Conant K, Haughey N, Turchan-Chelowo J, Hahn K, Rosen A, Steiner J, Keswani S, Jones M, Calabresi PA, Nath A. Wang T, et al. Among authors: calabresi pa. FASEB J. 2006 Jun;20(8):1209-11. doi: 10.1096/fj.05-5022fje. Epub 2006 Apr 24. FASEB J. 2006. PMID: 16636104
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. Rudick RA, et al. Among authors: calabresi pa. Ann Neurol. 2007 Oct;62(4):335-46. doi: 10.1002/ana.21163. Ann Neurol. 2007. PMID: 17696126 Clinical Trial.
Interleukin-17 in transverse myelitis and multiple sclerosis.
Graber JJ, Allie SR, Mullen KM, Jones MV, Wang T, Krishnan C, Kaplin AI, Nath A, Kerr DA, Calabresi PA. Graber JJ, et al. Among authors: calabresi pa. J Neuroimmunol. 2008 May 30;196(1-2):124-32. doi: 10.1016/j.jneuroim.2008.02.008. Epub 2008 Apr 16. J Neuroimmunol. 2008. PMID: 18417225
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
Krishnan C, Kaplin AI, Brodsky RA, Drachman DB, Jones RJ, Pham DL, Richert ND, Pardo CA, Yousem DM, Hammond E, Quigg M, Trecker C, McArthur JC, Nath A, Greenberg BM, Calabresi PA, Kerr DA. Krishnan C, et al. Among authors: calabresi pa. Arch Neurol. 2008 Aug;65(8):1044-51. doi: 10.1001/archneurol.65.8.noc80042. Epub 2008 Jun 9. Arch Neurol. 2008. PMID: 18541787 Free PMC article. Clinical Trial.
Reproducibility of optical coherence tomography in multiple sclerosis.
Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Cettomai D, et al. Among authors: calabresi pa. Arch Neurol. 2008 Sep;65(9):1218-22. doi: 10.1001/archneur.65.9.1218. Arch Neurol. 2008. PMID: 18779426
465 results